MaxCyte Inc (MXCT)
Industry Medical Devices
Sell
380.00p
Buy
384.00p
-23.00p (-5.68%)
Prices updated at 24 Jan 2025, 16:29 GMT
| Prices minimum 15 mins delay
Prices in GBX
MaxCyte Inc is a provider of technological solutions to pharmaceutical companies. Its key product is electroporation technology which is sold to companies which are engaged in drug discovery and development.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
22 Jan 202521 Jan 202517 Jan 202515 Jan 202513 Jan 202502 Jan 202531 Dec 202423 Dec 202419 Dec 202409 Dec 2024
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Aug 2025 |
| Annual general meeting | Jun 2025 |
| Final results | Mar 2025 |
| Annual report | Mar 2025 |
| Previous date | |
|---|---|
| Half yearly results | Aug 2024 |
| Annual general meeting | Jun 2024 |
| Final results | Mar 2024 |
| Annual report | Mar 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 